Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 7 studies | 33% ± 11% | |
| glutamatergic neuron | 5 studies | 36% ± 14% | |
| retina horizontal cell | 5 studies | 18% ± 2% | |
| GABAergic neuron | 5 studies | 34% ± 11% | |
| epithelial cell | 4 studies | 27% ± 6% | |
| oligodendrocyte precursor cell | 4 studies | 28% ± 8% | |
| interneuron | 4 studies | 34% ± 16% | |
| oligodendrocyte | 4 studies | 24% ± 2% | |
| endothelial cell | 3 studies | 20% ± 1% | |
| retinal rod cell | 3 studies | 19% ± 2% | |
| neuron | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 905.48 | 459 / 459 | 100% | 12.89 | 1116 / 1118 |
| esophagus | 100% | 707.54 | 1445 / 1445 | 99% | 8.98 | 182 / 183 |
| prostate | 100% | 903.49 | 245 / 245 | 99% | 10.96 | 499 / 502 |
| brain | 99% | 631.00 | 2623 / 2642 | 100% | 13.22 | 705 / 705 |
| thymus | 100% | 1025.93 | 653 / 653 | 99% | 9.68 | 599 / 605 |
| lung | 99% | 669.40 | 573 / 578 | 100% | 9.59 | 1152 / 1155 |
| pancreas | 99% | 401.79 | 326 / 328 | 99% | 6.91 | 176 / 178 |
| bladder | 100% | 812.05 | 21 / 21 | 98% | 7.70 | 495 / 504 |
| ovary | 100% | 1095.28 | 180 / 180 | 98% | 6.75 | 422 / 430 |
| intestine | 100% | 707.47 | 966 / 966 | 98% | 6.95 | 516 / 527 |
| stomach | 100% | 599.12 | 359 / 359 | 98% | 6.75 | 280 / 286 |
| uterus | 100% | 922.74 | 170 / 170 | 98% | 8.01 | 449 / 459 |
| kidney | 100% | 736.99 | 89 / 89 | 97% | 7.24 | 877 / 901 |
| skin | 100% | 1123.86 | 1809 / 1809 | 96% | 9.61 | 451 / 472 |
| adrenal gland | 100% | 1000.71 | 258 / 258 | 93% | 6.17 | 213 / 230 |
| liver | 100% | 489.12 | 226 / 226 | 88% | 4.10 | 359 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.19 | 29 / 29 |
| spleen | 100% | 898.78 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 8.61 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.91 | 1 / 1 |
| adipose | 100% | 753.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 613.02 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 420.62 | 798 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 398.52 | 814 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 6.39 | 74 / 80 |
| peripheral blood | 71% | 423.13 | 657 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043041 | Biological process | amino acid activation for nonribosomal peptide biosynthetic process |
| GO_0006631 | Biological process | fatty acid metabolic process |
| GO_0019482 | Biological process | beta-alanine metabolic process |
| GO_0016878 | Molecular function | acid-thiol ligase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | AASDH |
| Protein name | Aminoadipate-semialdehyde dehydrogenase Beta-alanine-activating enzyme (EC 6.2.1.-) (Acyl-CoA synthetase family member 4) (Protein NRPS998) |
| Synonyms | U26 ACSF4 HSPC318 |
| Description | FUNCTION: Covalently binds beta-alanine in an ATP-dependent manner to form a thioester bond with its phosphopantetheine group and transfers it to an, as yet, unknown acceptor. May be required for a post-translational protein modification or for post-transcriptional modification of an RNA. . |
| Accessions | ENST00000513376.5 [Q4L235-2] ENST00000502617.1 [Q4L235-3] R4GNB1 ENST00000514745.5 Q4L235 ENST00000205214.11 [Q4L235-1] D6RJA2 E9PH98 ENST00000503808.5 ENST00000602986.5 ENST00000451613.5 [Q4L235-4] |
